Corey Nislow completed his doctor of philosophy in University of Colorado. He was an American Cancer Society fellow, group leader in three biotechnology companies and senior genome scientist at Stanford University. Nislow is an Associate Professor, Director of the UBC Sequencing Centre and a Tier 1 Canada Research Chair. His work on drug-gene and drug-environment interactions is broad in scope, ranging from yeast to human and, as part of an ongoing collaboration with NASA and Duke University, he has flown experiments on 4 missions to the International Space Station. Nislow is Principal Investigator for the ‘Genomics for Precision Drug Therapy in Community Pharmacy’ project, which demonstrated that pharmacists are well positioned to convey pharmacogenomics information to their patients and their healthcare team. He has 185 peer-reviewed publications and 8 issued patents. He is passionate about using genomic technology to improve health and wellness.